 | Up a level |
Bruggmann, P.; Falcato, L.; Dober, S.; Helbling, B.; Keiser, O.; Negro, F.; Meili, D. (2008). Active intravenous drug use during chronic hepatitis C therapy does not reduce sustained virological response rates in adherent patients. Journal of viral hepatitis, 15(10), pp. 747-752. Blackwell Science 10.1111/j.1365-2893.2008.01010.x
